Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), composed of 44 amino acids and engineered with modifications to resist degradation by DPP-IV. This stability-enhancing design prolongs its half-life while allowing it to effectively stimulate endogenous, pulsatile growth hormone (GH) release and subsequent IGF-1 production. In research settings, Tesamorelin is used to explore metabolic regulation, such as enhanced lipolysis and improved glucose and lipid parameters, as well as potential benefits for peripheral nerve health and cognitive function.
This peptide is intended solely for in vitro and laboratory investigations.
For Research Use Only – Not for Human Consumption.